Stock 300573 SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Shenyang Xingqi Pharmaceutical Co.,Ltd.

Equities

300573

CNE100002DV1

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
259.6 CNY +0.55% Intraday chart for Shenyang Xingqi Pharmaceutical Co.,Ltd. +19.62% +42.38%
Apr. 26 Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80% MT
Apr. 25 Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80%
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Xingqi Pharma Gets Nod to Market Atropine Sulfate Eye Drop; Shares Up 3%
Shenyang Xingqi Pharmaceutical Co.,Ltd. Approves Board Elections
Xingqi Pharmaceutical's Diquafosol Sodium Eye Drops Bags China's Centralized Drug Bid
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Interim Dividend on A Shares for the Year 2023, Payable on 22 September 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Cash Interim Profit Distribution Plan for 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Interim Dividend for the First Half of 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Xingqi Pharmaceutical Enrolls First Subject for Phase 4 Trial of Eye Drops
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 22 May 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd Proposes Final Dividend for 2022
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shenyang Xingqi Pharmaceutical Co.,Ltd Announces Interim Dividend on A Shares for the Year 2021, Payable on September 23, 2022
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Interim Cash Dividend for 2022
Shenyang Xingqi Pharmaceutical Announces Profit Distribution Proposal for the First Half of 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300573 Stock
  4. News Shenyang Xingqi Pharmaceutical Co.,Ltd.
  5. Other languages